With Karuna Therapeutics 14B Deal, Bristol Myers Is Serious For Re-Establishing Its Neurology Portfolio Analyst

KRTXDelisted Stock  USD 203.11  1.46  0.71%   
Slightly above 62% of Karuna Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Karuna Therapeutics suggests that many traders are alarmed regarding Karuna Therapeutics' prospects. Karuna Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Karuna Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Earlier Friday, Bristol Myers Squibb Co agreed to acquire Karuna Therapeutics Inc for 330.00 per share in cash, for a total equity value of 14.0 billion, or 12.7 bill

Read at benzinga.com
benzinga news
  

Karuna Therapeutics Fundamental Analysis

We analyze Karuna Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Karuna Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Karuna Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Karuna Therapeutics is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Karuna Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Karuna Therapeutics stock to make a market-neutral strategy. Peer analysis of Karuna Therapeutics could also be used in its relative valuation, which is a method of valuing Karuna Therapeutics by comparing valuation metrics with similar companies.

Peers

Karuna Therapeutics Related Equities

INZYInozyme Pharma   9.56   
0%
100.0%
TERNTerns Pharmaceuticals   5.17   
0%
54.0%
MREOMereo BioPharma   1.58   
0%
16.0%
BPMCBlueprint Medicines   0.87   
0%
9.0%
XFORX4 Pharmaceuticals   0.45   
0%
4.0%
CYTKCytokinetics   0.1   
0%
1.0%
APLSApellis Pharmaceuticals   1.09   
11.0%
0%
DYNDyne Therapeutics   1.19   
12.0%
0%
DAWNDay One   1.86   
19.0%
0%
EWTXEdgewise Therapeutics   2.58   
26.0%
0%
ABOSAcumen Pharmaceuticals   3.56   
37.0%
0%
AMLXAmylyx Pharmaceuticals   7.58   
79.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Karuna Stock

If you are still planning to invest in Karuna Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karuna Therapeutics' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities